PEB · ASX

Pacific Edge Limited (ASX:PEB)

AU$0.14

 0.01 (7.407%)
ASX:Live
15/10/2024 02:19:53 PM
Recent Earnings upgrade HALO Price Momentum HALO Ords HALO Momentum HALO Earnings Momentum +3
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PEB Overview

PEB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About PEB

Website

N/A

Telephone

64.3.479.5800

Address

87 St. David Street Centre for Innovation Dunedin, Otago 9016

Description

N/A

PEB Price Chart

Key Stats

Market Cap

AU$113.77M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.07 - 0.18

Trade Value (12mth)

AU$633.00

1 week

12.5%

1 month

66.67%

YTD

22.73%

1 year

35%

All time high

1.61

Key Fundamentals

EPS 3 yr Growth

35.50%

EBITDA Margin

-132.20%

Operating Cashflow

-$24m

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

-56.80

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

811m

HALO Sector

Healthcare

Next Company Report Date

29-May-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.13

PEB Announcements

Latest Announcements

Date Announcements

09 October 24

Pacific Edge Release Quarterly Volumes for Q2 FY25

×

Pacific Edge Release Quarterly Volumes for Q2 FY25

24 September 24

Chair's Address to Shareholders

×

Chair's Address to Shareholders

24 September 24

Results of Meeting

×

Results of Meeting

19 September 24

Change in substantial holding

×

Change in substantial holding

13 September 24

AUA Micro-Hematuria Guideline and Medicare Timelines

×

AUA Micro-Hematuria Guideline and Medicare Timelines

05 September 24

Pacific Edge Chairman Delays Retirement

×

Pacific Edge Chairman Delays Retirement

15 August 24

Notice of Annual Shareholder Meeting and Proxy Form 2024

×

Notice of Annual Shareholder Meeting and Proxy Form 2024

29 July 24

Novitas Confirms Medicare Coverage Review Extension

×

Novitas Confirms Medicare Coverage Review Extension

26 July 24

Medicare Coverage Determination Still Under Review

×

Medicare Coverage Determination Still Under Review

16 July 24

Director Nomination Closing Date

×

Director Nomination Closing Date

11 July 24

Notification regarding unquoted securities - PEB

×

Notification regarding unquoted securities - PEB

11 July 24

Application for quotation of securities - PEB

×

Application for quotation of securities - PEB

10 July 24

Quarterly Update - Cxbladder Test Volumes Steady in Q1 25

×

Quarterly Update - Cxbladder Test Volumes Steady in Q1 25

09 July 24

Notification of cessation of securities - PEB

×

Notification of cessation of securities - PEB

27 June 24

Annual Report 2024

×

Annual Report 2024

21 May 24

Cash Burn Slows Coverage Catalysts in Focus

×

Cash Burn Slows Coverage Catalysts in Focus

01 May 24

Pacific Edge Full Year Result to be Announced 21 May 2024

×

Pacific Edge Full Year Result to be Announced 21 May 2024

01 May 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

01 May 24

Becoming a substantial holder

×

Becoming a substantial holder

30 April 24

Clinical Utility of Cxbladder to Headline at AUA 2024

×

Clinical Utility of Cxbladder to Headline at AUA 2024

09 April 24

Quarterly Update - Cxbladder Test Volumes Steady in Q4 24

×

Quarterly Update - Cxbladder Test Volumes Steady in Q4 24

14 March 24

Pacific Edge Directors Give Notice of Retirement

×

Pacific Edge Directors Give Notice of Retirement

22 January 24

Quarterly Update - Test Volumes Fall Following Restructure

×

Quarterly Update - Test Volumes Fall Following Restructure

22 January 24

Cxbladder Test Volumes Correction

×

Cxbladder Test Volumes Correction

15 December 23

Application for quotation of securities - PEB

×

Application for quotation of securities - PEB

PEB Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.03 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.03 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.7 -11.6 2.6 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.03 -0.03 -0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.03 -0.03 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -31.1 -11.4 14.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock -7.7 -39.0 N/A Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.10 0.06 0.06 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.09 0.06 0.09 Lock Lock Lock
     Growth % Lock Lock Lock Lock -23.7 -35.6 50.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 810 811 N/A Lock Lock Lock
Basic m Lock Lock Lock Lock 810 811 N/A Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 18 22 22 Lock Lock Lock
     Growth % Lock Lock Lock Lock 65.7 24.0 -1.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 39 43 54 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 9 10 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 103.5 19.6 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 49.0 47.2 N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 51 53 N/A Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -29 -30 -29 Lock Lock Lock
     Growth % Lock Lock Lock Lock -46.2 -4.9 3.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -159.7 -135.1 -132.2 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 2 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -30 -32 -30 Lock Lock Lock
     Growth % Lock Lock Lock Lock -45.7 -6.1 5.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -170.6 -146.0 -139.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -26 -29 N/A Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 N/A Lock Lock Lock
Net Income $m Lock Lock Lock Lock -25 -27 -27 Lock Lock Lock
     Growth % Lock Lock Lock Lock -31.7 -11.4 1.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -137.5 -123.5 -123.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -23 -24 -24 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 3 1 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 20 21 16 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -25 -25 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -45.2 1.5 6.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.4 -1.1 -1.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 73 46 N/A Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 85 60 60 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 2 N/A Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -72 -42 -38 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 8 10 N/A Lock Lock Lock
Equity $m Lock Lock Lock Lock 77 50 50 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 78 52 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -23.2 -32.6 N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -28.9 -45.6 -45.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -31.8 -54.7 -53.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -33.8 -48.9 N/A Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -27.5 -42.1 N/A Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -26.1 -36.7 N/A Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -2,409.8 -1,537.9 -56.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.5 1.4 1.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -92.5 -84.6 -75.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 11.1 7.0 N/A Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 10.9 6.8 N/A Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 90.5 86.8 N/A Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -322.3 -313.0 -151.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.0 4.7 N/A Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 8.5 8.5 N/A Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.2 0.5 N/A Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 11.4 8.9 N/A Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.4 0.4 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.4 0.4 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -144.5 -129.0 N/A Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -30.4 -47.6 N/A Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -28.9 -45.6 -45.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.2 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -31.8 -54.7 -53.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 132.9 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -31.8 -54.7 -71.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 42.7 42.9 N/A Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 90.3 77.7 N/A Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 133.1 120.6 N/A Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 73.8 60.8 N/A Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 59.2 59.9 N/A Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PEB Shortsell

Frequently Asked Questions

The current share price of Pacific Edge Limited (PEB:ASX) is AU$0.14.
The 52-week high share price for Pacific Edge Limited (PEB:ASX) is AU$0.18.
The 52-week low share price for Pacific Edge Limited (PEB:ASX)? is AU$0.07.
Pacific Edge Limited (PEB:ASX) does not pay a dividend.
Pacific Edge Limited (PEB:ASX) does not pay a dividend.
Pacific Edge Limited (PEB:ASX) has a franking level of 0.0%.
Pacific Edge Limited (PEB:ASX) is classified in the Healthcare.
The current P/E ratio for Pacific Edge Limited (PEB:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.